Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

VolitionRx says underwriter exercises over-allotment option

Friday, October 21, 2016 12:46
% of readers think this story is Fact. Add your two cents.

(Before It's News)

VolitionRx Limited (NYSEMKT:VNRX) shares gained on Friday after the company said the Underwriter of its public offering of 2.25mln shares has exercised its option to purchase an additional 234,404 shares at $5 per share to cover over-allotments, bringing the total gross proceeds from the offering to approximately $12.4mln.

The Namur, Belgium-based life sciences company focused on developing diagnostic tests for cancer said the net proceeds are expected to be approximately $11.7mln, after deducting underwriting discounts, commissions and estimated offering expenses payable by Volition.

All of the shares in the offering and the over-allotment were offered by Volition. The exercise of the over-allotment option closed on October 21.

National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NASDAQ:NHLD), acted as sole book-running manager for the offering. Lake Street Capital Markets and The Benchmark Company, LLC acted as advisors in the offering.

Volition intends to use the net proceeds of the offering for continued product development, clinical studies, product commercialization, working capital, and for other general corporate purposes.

VolitionRx shares were up 2.8% at $4.85 on Friday.

Story by ProactiveInvestors

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.